Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.37 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.37 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27313495 | 0.98 | DNM1 (0.47) | DNM1USP2SPHK1HTTLPAR1 | |
| SCHEMBL5358156 | 0.93 | TSHR (0.37) | DNM1USP2SPHK1HTTALDH1A1 | |
| SCHEMBL10379772 | 0.86 | DNM1 (0.43) | DNM1USP2SPHK1HTTALDH1A1 | |
| SCHEMBL31253233 | 0.84 | DNM1 (0.47) | DNM1USP2SPHK1HTTALDH1A1 | |
| SCHEMBL16004875 | 0.84 | DNM1 (0.47) | DNM1USP2SPHK1HTTALDH1A1 | |
| SCHEMBL10441645 | 0.84 | DNM1 (0.47) | DNM1USP2SPHK1HTTALDH1A1 | |
| SCHEMBL4248716 | 0.84 | DNM1 (0.47) | DNM1USP2SPHK1HTTALDH1A1 | |
| SCHEMBL4244542 | 0.84 | DNM1 (0.47) | DNM1USP2SPHK1HTTALDH1A1 | |
| SCHEMBL409835 | 0.84 | DNM1 (0.47) | DNM1USP2SPHK1HTTALDH1A1 | |
| SCHEMBL10441897 | 0.84 | DNM1 (0.47) | DNM1USP2SPHK1HTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109923707-B | Carbon-silicon composite material, negative electrode, secondary battery, and method for producing carbon-silicon composite material | 太克万株式会社 | 2022-05-03 | — | — | CN | disclosed |
| CN-107820645-B | Carbon-silicon composite material, negative electrode and secondary battery | 太克万株式会社 | 2020-02-14 | — | — | CN | disclosed |
| CN-100439417-C | Method of crystallizing polycarbonate prepolymer | GEN ELECTRIC (NL) | 2008-12-03 | — | — | CN | disclosed |
| EP-1054993-B1 | PROCESS FOR THE OBTAINING OF HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY | LEK TOVARNA FARMACEVTSKIH (SI) | 2005-05-25 | — | — | EP | disclosed |
| CN-1182948-C | Process for preparing porous prepolymer pellets | ͨ�õ�����˾ | 2005-01-05 | — | — | CN | disclosed |
| US-6825015-B1 | Process for the obtaining of HMG-COA reductase inhibitors of high purity | LEK PHARMACEUTICALS D.D. (SI) | 2004-11-30 | — | — | US | disclosed |
| US-6806290-B2 | LOVASTATIN, PRAVASTATIN, SIMVASTATIN, MEVASTATIN, ATORVASTATIN, AND DERIVATIVES AND ANALOGS THEREOF ARE KNOWN AS HMG-COA REDUCTASE INHIBITORS AND ARE USED AS ANTIHYPERCHOLESTEROLEMIC AGENTS. THE MAJORITY OF THEM ARE | LEK PHARMACEUTICALS D.D. (SI) | 2004-10-19 | — | — | US | disclosed |
| EP-1292293-B1 | STABILIZED PHARMACEUTICALLY EFFECTIVE COMPOSITION AND PHARMACEUTICAL FORMULATION COMPRISING THE SAME | LEK TOVARNA FARMACEVTSKIH (SI) | 2004-02-25 | — | — | EP | disclosed |
| US-20030109584-A1 | Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same | LEK PHARMACEUTICALS D.D. (SI) | 2003-06-12 | — | — | US | disclosed |
| EP-1292293-A1 | STABILIZED PHARMACEUTICALLY EFFECTIVE COMPOSITION AND PHARMACEUTICAL FORMULATION COMPRISING THE SAME | Lek Pharmaceutical and Chemical Co. D.D. (SI) | 2003-03-19 | — | — | EP | disclosed |
| EP-0094261-B1 | ONE-COMPONENT MOISTURE CURABLE URETHANE COATING SYSTEM | The Lubrizol Corporation (US) | 1986-12-03 | — | — | EP | disclosed |
| US-4615813-A | DRILLING FLUIDS | THE LUBRIZOL CORPORATION (US) | 1986-10-07 | — | — | US | disclosed |
| EP-0094196-B1 | TWO-COMPONENT URETHANE COATING SYSTEM | The Lubrizol Corporation (US) | 1986-08-27 | — | — | EP | disclosed |
| US-4582543-A | WITH AN OVERBASED COMPOUND-CORROSION INHIBITING COATING | THE LUBRIZOL CORPORATION (US) | 1986-04-15 | — | — | US | disclosed |
| US-4468339-A | AND SOLUBILIZER WHICH IS REACTION OF CARBOXYLIC ACID ACYLATING AGENT WITH HYDROCARBON SUBSTITMENT AND HYDROXYAMINE | THE LUBRIZOL CORPORATION (US) | 1984-08-28 | — | — | US | disclosed |
| US-4443577-A | COLLOIDAL DISPERSE SYSTEM, OVERBASED SALTS | THE LUBRIZOL CORPORATION (US) | 1984-04-17 | — | — | US | disclosed |
| US-4436855-A | DIISOCYANATE AND ORGANIC PHOSPHATE | THE LUBRIZOL CORPORATION (US) | 1984-03-13 | — | — | US | disclosed |
| EP-0094261-A2 | One-component moisture curable urethane coating system | The Lubrizol Corporation (US) | 1983-11-16 | — | — | EP | disclosed |
| EP-0094196-A2 | Two-component urethane coating system | The Lubrizol Corporation (US) | 1983-11-16 | — | — | EP | disclosed |
| EP-0084966-A2 | Aqueous compositions containing overbased materials | The Lubrizol Corporation (US) | 1983-08-03 | — | — | EP | disclosed |